Back to search
Hereditary Spherocytosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Spherocytosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Spherocytosis trials you may qualify forINTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and geneti…
Human splenic physiology remains poorly understood due to lack of functional exploration. However, through its ability to recognize alterations or modifications…
Background : Patients with hereditary spherocytosis (HS) are characterized by increased red blood cell (RBC) fragility and a loss of RBC deformability. While th…
Patients with red blood cell disorders (RBCDs), such as Sickle cell disease (SCD) and Thalassemia, are chronic, life-threatening conditions that can become mult…
The purpose of this study is to describe the range and incidence of symptoms, treatments, and complications related to pyruvate kinase deficiency (PKD). Eligibl…